Founder of Harocalyx Bio, an early-stage biotechnology company dedicated to improving outcomes for patients with glioblastoma. Inspired by my family's experience with GBM, I am building a mission-driven company focused on developing innovative therapies for MGMT-unmethylated glioblastoma. I'm currently connecting with scientists, advisors, and collaborators in neuro-oncology, CNS therapeutics, and translational medicine to help advance our research and long-term vision.